Have a personal or library account? Click to login
Role of Quetiapine in the Prevention of ICU Delirium in Elderly Patients at a High Risk Cover

Role of Quetiapine in the Prevention of ICU Delirium in Elderly Patients at a High Risk

Open Access
|Oct 2024

Figures & Tables

Fig. 1.

The side effects of Quetiapine among the patients in group Q
The side effects of Quetiapine among the patients in group Q

Demographics and clinical parameters of patients among the two groups

Group QGroup CP value
Age [mean ± SD]68.7 ± 7.671.2 ± 5.70.02

Gender [n (%)]
Male19 (42%)15 (33%)0.38
Female26 (58%)30 (67%)

Co-morbidities [n (%)]
Respiratory diseases4 (9%)5 (11%)0.5
Metabolic diseases2 (5%)8 (18%)
Cardiac diseases16 (36%)17 (37%)
Neurological diseases2 (4%)0 (0%)
Multiple20 (44%)15 (34%)

qSOFA Score [median (IQR)]3 (1–6)3 (1–4)0.0001

Length of hospital stay [median (IQR)]15 (10–19)10 (5–14)0.001

Intensive care delirium screening checklist (ICDSC)

Main itemSubitem
1. Altered level of consciousness:A: No response
B: Response to intense and repeated stimulation
C: Response to mild or moderate stimulation
D: Normal wakefulness
E: Exaggerated response to normal stimulation
2. Inattentiveness:Difficulty following instructions or easily distracted
3. Disorientation To time, place, or person
4. Hallucination-delusion-psychosis:Clinical manifestation or suggestive behavior
5. Psychomotor agitation or retardation:Agitation requiring use of drugs or restraints, or slowing
6. Inappropriate speech or mood:Related to events or situation, or incoherent speech
7. Sleep/wake cycle disturbance:Sleeping < 4hrs day, walking all the night, sleeping all day
8. Symptom fluctuation Symptoms above occurring intermittently

Risk factors for ICU delirium among the two groups

Group QGroup CP value
Immobilization [n (%)]37 (82%)21 (47%)0.0004
Urinary catheter [n (%)]33 (73%)26 (58%)0.12
Infection [n (%)]37 (82%)19 (42%)0.0001
Visual Impairment [n (%)]8 (18%)23 (51%)0.0008
Auditory impairment [n (%)]11 (24%)17 (38%)0.17
Hemoglobin [gm/dl, mean ± SD]9.7 ± 1.89.6 ± 1.50.13
Analgesic & Sedative [n (%)]17 (38%)16 (36%)0.83
Shocked [n (%)]8 (18%)9 (20%)0.78
Intubated [n (%)]2 (4%)0 (0%)0.25
Metabolic abnormalities [n (%)]40 (89%)34 (76%)0.09

Comparison between the cases presented with delirium among the two groups

Group Q N (%)Group C N (%)P value
DeliriumNo34 (75%)23 (51%)0.01
Hypoactive9 (20%)5 (11%)
Hyperactive2 (5%)17(38%)

CAM-ICU-7 and ICDSE scores among the two groups

Group QGroup CP value

MinMaxMedian (IQR)MinMaxMedian (IQR)
CAM-ICU-7072 (0–3)072 (0–6)0.37
ICDSC070 (0–2)070 (0–4)0.06
DOI: https://doi.org/10.2478/jccm-2024-0032 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 361 - 367
Submitted on: Oct 26, 2023
Accepted on: Jul 10, 2024
Published on: Oct 31, 2024
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Walid Y. Kamel, Heba Y. Kamel, Ibrahim M. Elsherif, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.